CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company
ADC Therapeutics SA
Sign in to watch- Ticker
- ADCT
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- Phone
- 41 21 653 02 00
- Business address
- BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
- S-3 Offering Registration Statement
- ARS Other Annual Report to Security Holders
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Chief Accounting Officer acquired 62,900 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 285,200 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 294,800 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 271,600 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 900,000 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 3 of 23 · 441 filings